Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

CD101: A New Long-Acting Echinocandin

OCT 07, 2017 | CONTAGION® EDITORIAL STAFF


David Andes, MD, professor and chief of infectious disease at the University of Wisconsin, shares the half-life and dosing intervals for a new long-acting echinocandin.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
Big advances in treatment can